Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02609633 · ClinicalTrials.gov registry record · NA
Accu-Chek® CONNECT at School (CATS) Pediatric Study
A NA study, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- NA
- Development phase
- 196
- Enrollment target
NCT02609633 is a NA study that has completed, run by Hoffmann-La Roche. The registered enrollment target is 196 participants.
The verdict
NCT02609633, a NA study, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- NA
- Development phase
- 196 participants
- Enrollment target
Study Summary
This interventional, 6-month post-marketing study is designed to evaluate the change in diabetes-related distress among parents/caregivers of school-age children and adolescents with type 1 diabetes (T1D) who are receiving multiple daily injections (MDI) therapy. Investigational sites will be assigned using cluster randomization, with approximately 10 to 20 children at each site. In order to maintain a true control group for comparison, the investigational sites will be randomly assigned to the Accu-Chek® CONNECT Diabetes Management System (DMS) or usual care/continued use of current DMS devices.
Interventions
- DEVICE Accu-Chek® CONNECT DMS
- DEVICE DMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2015-12-28 |
| Est. Completion | 2017-01-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02609633
The ClinicalTrials.gov registry entry for NCT02609633 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 196 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Accu-Chek® CONNECT DMS is the first listed.
NCT02609633 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02609633 about?
NCT02609633 is a clinical study titled "Accu-Chek® CONNECT at School (CATS) Pediatric Study". This interventional, 6-month post-marketing study is designed to evaluate the change in diabetes-related distress among parents/caregivers of school-age children and adolescents with type 1 diabetes (T1D) who are receiving multiple daily injections (MDI) therapy. Investigational sites will be assign...
What is the current status of trial NCT02609633?
This trial is currently completed. It is a NA study. The enrollment target is 196 participants. The study started on 2015-12-28. Estimated completion is 2017-01-20.
What interventions are being tested in trial NCT02609633?
The interventions under investigation include: Accu-Chek® CONNECT DMS (DEVICE), DMS (DEVICE).
Who is sponsoring clinical trial NCT02609633?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.